Logo image of TPCO

Tribune Publishing Company (TPCO) Stock Fundamental Analysis

NASDAQ:TPCO - Nasdaq -

17.26  +0.07 (+0.41%)

After market: 17.26 0 (0%)

Fundamental Rating

3

Taking everything into account, TPCO scores 3 out of 10 in our fundamental rating. TPCO was compared to 0 industry peers in the Unkown industry. The financial health of TPCO is average, but there are quite some concerns on its profitability. TPCO has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year TPCO was profitable.

1.2 Ratios

Industry RankSector Rank
ROA 6.18%
ROE 11.18%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 0.99%
PM (TTM) 4.63%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

6

2. Health

2.1 Basic Checks

There is no outstanding debt for TPCO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 3.68 indicates that TPCO is not in any danger for bankruptcy at the moment.
There is no outstanding debt for TPCO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.68
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 2.03 indicates that TPCO has no problem at all paying its short term obligations.
TPCO has a Quick Ratio of 1.99. This is a normal value and indicates that TPCO is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 1.99

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 145.83% over the past year.
Looking at the last year, TPCO shows a very negative growth in Revenue. The Revenue has decreased by -25.31% in the last year.
Measured over the past years, TPCO shows a very negative growth in Revenue. The Revenue has been decreasing by -14.91% on average per year.
EPS 1Y (TTM)145.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%137.37%
Revenue 1Y (TTM)-25.31%
Revenue growth 3Y-9.76%
Revenue growth 5Y-14.91%
Sales Q2Q%-19.83%

3.2 Future

TPCO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 141.06% yearly.
Based on estimates for the next years, TPCO will show a decrease in Revenue. The Revenue will decrease by -6.10% on average per year.
EPS Next Y254.46%
EPS Next 2Y147.04%
EPS Next 3Y137.66%
EPS Next 5Y141.06%
Revenue Next Year11.5%
Revenue Next 2Y-4.58%
Revenue Next 3Y-3.29%
Revenue Next 5Y-6.1%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TPCO Yearly Revenue VS EstimatesTPCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
TPCO Yearly EPS VS EstimatesTPCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

TPCO is valuated quite expensively with a Price/Earnings ratio of 26.15.
Compared to an average S&P500 Price/Earnings ratio of 26.76, TPCO is valued at the same level.
Based on the Price/Forward Earnings ratio of 11.43, the valuation of TPCO can be described as reasonable.
TPCO is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.91, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 26.15
Fwd PE 11.43
TPCO Price Earnings VS Forward Price EarningsTPCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.29
TPCO Per share dataTPCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TPCO's earnings are expected to grow with 137.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y147.04%
EPS Next 3Y137.66%

More info and screens

0

5. Dividend

5.1 Amount

TPCO has a Yearly Dividend Yield of 1.45%.
TPCO's Dividend Yield is slightly below the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 1.45%

5.2 History

The dividend of TPCO decreases each year by -21.91%.
TPCO is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)-21.91%
Div Incr YearsN/A
Div Non Decr YearsN/A
TPCO Yearly Dividends per shareTPCO Yearly Dividends per shareYearly Dividends per share 2019 2020 0.05 0.1 0.15 0.2

5.3 Sustainability

The earnings of TPCO are negative and hence is the payout ratio. TPCO will probably not be able to sustain this dividend level.
DP-15.74%
EPS Next 2Y147.04%
EPS Next 3Y137.66%

More info and screens

Tribune Publishing Company

NASDAQ:TPCO (5/24/2021, 8:00:01 PM)

After market: 17.26 0 (0%)

17.26

+0.07 (+0.41%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.01%
Inst Owner Change0%
Ins Owners1.3%
Ins Owner Change0%
Market Cap636.45M
Analysts0
Price Target20.4 (18.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.45%
Yearly Dividend0.25
Dividend Growth(5Y)-21.91%
DP-15.74%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 26.15
Fwd PE 11.43
P/S 0.89
P/FCF N/A
P/OCF N/A
P/B 2.15
P/tB N/A
EV/EBITDA 11.29
EPS(TTM)0.66
EY3.82%
EPS(NY)1.51
Fwd EY8.75%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS19.35
BVpS8.02
TBVpSN/A
PEG (NY)0.1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.18%
ROE 11.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 0.99%
PM (TTM) 4.63%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.03
Quick Ratio 1.99
Altman-Z 3.68
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)145.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%137.37%
EPS Next Y254.46%
EPS Next 2Y147.04%
EPS Next 3Y137.66%
EPS Next 5Y141.06%
Revenue 1Y (TTM)-25.31%
Revenue growth 3Y-9.76%
Revenue growth 5Y-14.91%
Sales Q2Q%-19.83%
Revenue Next Year11.5%
Revenue Next 2Y-4.58%
Revenue Next 3Y-3.29%
Revenue Next 5Y-6.1%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A